| Name: |
Nadav Merhavi, Eytan Kreiner |
| Designation: |
- |
| Country: |
Israel |
| Address: |
- |
| Tel: |
972-8-9264554 |
| Mobile: |
- |
| Fax: |
- |
| E-mail:
|
dr.eytan@vetdoctors.co.il |
| Website: |
www.vetdoctors.co.il |
| Technology
Classification: |
Biotechnology |
| Main
Business Activity: |
- |
Company
Profile, Products & Technologies, Target Market
The House of Veterinary Doctors is a
company devoted to veterinary care of pets. The company serves as a
center for research in the field of veterinary medicine (stem cells,
innovative treatment of prostate pathologies and much more) as well as
an educational center for future veterinarians and nature preservation
activists.
Brief
description of proposed R&D project:
The House of Veterinary Doctors is
forming the first ever veterinary stem cells bank. The bank will allow,
for the very first time, the production and clinical use of
differentiated stem cells for the treatment of various illnesses in
animals (e.g bone and ligaments pathologies). The production of stem
cells will involve the use of innovative laboratory methods with the
help of Professor Dan Gazit and Doctor Zulma Gazit from the Hebrew
University. The Gazit group are well known internationally in the field
of stem cell research
Desired
Profile of R&D Partner and its role in the proposed R&D
project:
The partner should be involved in
Biotechnological R&D programs and with established financial
capabilities. As the project involves cell biology and veterinary
aspects, a partner with established experience in these areas would be
advantageous. In addition, a well established business and commercial
contacts are essential.
The partnering company should be
privately owned. The number of employees should be no more than 1000.
The partnering company should be involved in biotechnological projects.
House of Veterinary Doctors’ main interests are in cell biology,
cell storage and genetic manipulation of cells. If the company has
experience in stem cells, it would be advantageous.
It is not a necessity that the company is involved in veterinary
services alone, a company involved in human biotechnological projects
could also be a potential partner. Contact relations with educational
institutions (vet/human hospitals or universities) would be
advantageous.
Local veterinarians could be potential partner. The local vet should
have minimal experience in R&D projects, some kind of innovative
product and a large variety of clients.
|